1595P Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience

Autor: Buriolla, S., Pravisano, F., Costa, J., Alberti, M., Bortolus, G., Zapelloni, G., De Pieri, G., Targato, G., Pascoletti, G., Puglisi, F., Fasola, G., Minisini, A.M.M.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S887-S887
Databáze: ScienceDirect